The fact that only a limited number of genes, among which DMT3A, TET2, and ASXL1 are the most frequent, are mutated in CH, makes the goal to develop robust and inexpensive initial diagnostics of CH fairly feasible. This evidence concerns the gene TET2 and cyclic hematopoiesis.